Leptin: A potent inhibitor of insulin secretion

Peptides

Volumn 18, Issue 8, 1997, Pages 1267-1273

  Fehmann, Hans Christoph ^a,b   Peiser, Christian ^b   Bode, Hans Peter ^b   Stamm, Matthias ^a   Staats, Petra ^a   Hedetoft, Christoffer ^a   Lang, Rudolf Ernst ^b   Göke, Burkhard ^a  

^a Clin Res U Gastrointest E   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Glucagon; Insulin; Leptin; Pancreas; Receptor

Indexed keywords

CALCIUM ION; GLUCAGON; INSULIN; LEPTIN;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; FEEDBACK SYSTEM; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; HAMSTER; HUMAN; INSULIN RELEASE; MALE; MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CARRIER PROTEINS; CELLS, CULTURED; CRICETINAE; GLUCAGON; INSULIN; INSULIN ANTAGONISTS; ISLETS OF LANGERHANS; LEPTIN; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED DBA; PROTEINS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; RNA; TUMOR CELLS, CULTURED;

ANIMALIA; CRICETINAE;

EID: 0031470122     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00135-6     Document Type: Article

References (43)

1. Ahima R. S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J. S. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
2. Asfari M., Janjic D., Meda P., Li G., Halban P. A., Wollheim C. B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology. 130:1992;167-178.
3. Banks W. A., Kastin A. J., Huang W., Jaspan J. B., Maness J. M. Leptin enters the brain by a saturable system independent of insulin. Peptides. 17:1996;302-311.
4. Baumann H., Morella K. K., White D. W., Dembski M., Bailon P. S., Kim H., Lai C. F., Tartaglia L. A. The full-length leptin receptor has signalling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA. 93:1996;8374-8378.
5. Bode H. P., Göke B. Protein kinase C activates capacitative calcium entry in the insulin secreting cell line RINm5F. FEBS Lett. 339:1994;307-311.
6. Campfield L. A., Smith F. J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein Evidence for a peripheral signal linking adiposity and central neural networks . Science. 269:1995;546-549.
7. Chen H., Charlat O., Tartaglia L. A., Woolf E. A., Weng X., Ellis S. J., Lakey N. D., Culpepper J., Moore K. J., Breitbart R. E., Duyk G. M., Tepper R. I., Morgenstern J. P. Evidence that the diabetes gene encodes the leptin receptor Identification of a mutation in the leptin receptor gene in db/db mice . Cell. 84:1996;491-495.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Cohen B., Novick D., Rubinstein M. Modulation of insulin activities by leptin. Science. 274:1996;1185-1188.
10. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., McKee L. J., Bauer T. L., Caro J. F. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:1996;292-295.
11. Considine R. V., Considine E. L., Williams C. J., Nyce M. R., Magosin S. A., Bauer T. L., Rosato E. L., Colbert J., Caro J. F. Evidence against either a premature stop codon or the absence on obese gene mRNA in human obesity. J. Clin. Invest. 95:1995;2986-2988.
12. DeVos P., Saladin R., Auwerx J. ; Staels. B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270:1995;15958-15961.
13. Frederich R. C., Hamann A., Anderson S., Loffman B., Lowell B. B., Flier J. S. Leptin levels reflect body lipid content in mice evidence for diet-induced resistance to leptin action . Nature Med. 1:1996;1311-1314.
14. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M. H., Skoda R. C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA. 93:1996;6231-6235.
15. 2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J. Biol. Chem. 267:1992;20713-20720.
16. Grodsky G. M., Batts A. A., Bennett L. I., Vcella C., McWilliams N. D., Smith D. F. Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Am. J. Physiol. 205:1963;638-644.
17. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
18. Halaas J. L., Gajiwala K. S., Maffei M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M. Weight reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
19. Hamilton B. S., Paglia D., Kwan A. Y. M., Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med. 1:1995;953-956.
20. Hosoda K., Masuzaki H., Ogawa Y., Miyawaki T., Hiraoka J., Hanaoka I., Yasuno A., Nomura T., Fujisawa Y., Yoshimasa Y., Nishi S., Yamori Y., Nakao K. Development of radioimmunoassay for human leptin. Biochem. Biophys. Res. Commun. 221:1996;234-239.
21. Kallen C. B., Lazar M. A. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA. 93:1996;5793-5796.
22. Kieffer T. J., Heller R. S., Habener J. F. Leptin receptors expressed on pancreatic β-cells. Biochem. Biophys. Res. Commun. 224:1996;522-527.
23. Klein S., Coppack S. W., Mohamed-Ali V., Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes. 45:1996;984-987.
24. Lonnquist F., Arner P., Nordfors L., Schalling M. Overexpression of the obese (OB) gene in adipose tissue of human obese subjects. Nature Med. 1:1995;950-953.
25. MacDougald O. A., Hwang C. S., Fan H., Lane M. D. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA. 92:1995;9034-9037.
26. Malik K. F., Young W. S. III. Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology. 137:1996;1497-1500.
27. Malmström R., Taskinen M. R., Karonen S. L., Yki-Järvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia. 39:1996;993-996.
28. Mantzoros C. S., Qu D., Frederich R. C., Susulic V. S., Lowell B. B., Maratos-Flier E., Flier J. S. Activation of β3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 45:1996;909-914.
29. McGregor G. P., Desaga J. F., Ehlenz K., Fischer A., Heese F., Hegele A., Lämmer C., Peiser C., Lang R. E. Radioimmunological measurement of leptin in plasma of manual and diabetic human subjects. Endocrinology. 137:1996;1501-1504.
30. Nolan J. J., Olefsky J. M., Nyce M. R., Considine R. V., Caro J. F. Effect of troglitazone on leptin production studies in vitro and in human subjects . Diabetes. 45:1996;1276-1278.
31. Pelleymounter M. A., Cullen M. J., Baker M. B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:1995;541-543.
32. Rentsch J., Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett. 379:1996;55-59.
33. Saladin R., DeVos P., Guerro-Millo M., Leturque A., Girard J., Staels B. ; and Auwerx, J. Transient increase in obese gene expression after food intake of insulin administration. Nature. 377:1995;527-529.
34. Schwartz M. W., Baskin D. G., Bukowski T. R., Kuijper J. L., Foster D., Lasser G., Prunkard D. E., Porte D. Jr, Woods S. C., Seeley R. J., Weigle D. S. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:1996;531-535.
35. Segal K. R., Landt M., Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 45:1996;988-991.
36. Sivitz W. I., Bailey H. L., Donohue P. Rat adipose ob mRNA levels in states of altered circulating glucose and insulin. Biochem. Biophys. Res. Commun. 220:1996;520-525.
37. Slieker L. J., Sloop K. W., Surface P. L., Kriauciunas A., Valleskey J. B., Stephens T. W. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J. Biol. Chem. 271:1996;5301-5304.
38. Stephens T. W., Basinski M., Bristow P. K., Bue-Valleskey J. M., Burgett S. G., Craft L., Hale J., Hoffmann J., Hsiung H. M., Kriauciunas A., MacKellar W., Rosteck P. R. Jr, Schoner B., Smith D., Tinsley F. C., Zhang X. Y., Helman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
39. Tartaglia L. A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G. J., Campfield L. A., Clark F. T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K. J., Smutko J. S., Mays G. G., Woolf E. A., Monroe C. A., Tepper R. I. Identification and expression cloning of a leptin receptor. OB-R. Cell. 83:1995;1263-1271.
40. 2+ concentrations resemble bursting electrical activity in single mouse islets of Langerhans. FEBS Lett. 259:1989;19-23.
41. 2+ and insulin release in an insulin-secreting cell line. J. Biol. Chem. 259:1994;2262-2267.
42. Zhang B., Graziano M. P., Doebber T. W., Leibowitz M. D., White-Carrington S., Szalkowski D. M., Hey P. J., Wu M., Cullinan C. A., Bailey P., Lollmann B., Frederich R., Flier J. S., Strader C. D., Smith R. G. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in zucker diabetic fatty rats and db/db mice. J. Biol. Chem. 271:1996;9455-9459.
43. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-431.